Aurobindo Pharma subsidiary gets approval for oncology biosimilar Bevqolva from UK’s MHRA
Aurobindo Pharma Limited has recently informed exchanges that its subsidiary, CuraTeQ Biologics received approval for its bevacizumab biosimilar, Bevqolva, from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA). Bevqolva 25 mg/mL …